These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 26581806)
1. Beneficial impact of Gpnmb and its significance as a biomarker in nonalcoholic steatohepatitis. Katayama A; Nakatsuka A; Eguchi J; Murakami K; Teshigawara S; Kanzaki M; Nunoue T; Hida K; Wada N; Yasunaka T; Ikeda F; Takaki A; Yamamoto K; Kiyonari H; Makino H; Wada J Sci Rep; 2015 Nov; 5():16920. PubMed ID: 26581806 [TBL] [Abstract][Full Text] [Related]
2. GPNMB plays a protective role against obesity-related metabolic disorders by reducing macrophage inflammatory capacity. Prabata A; Ikeda K; Rahardini EP; Hirata KI; Emoto N J Biol Chem; 2021 Nov; 297(5):101232. PubMed ID: 34582891 [TBL] [Abstract][Full Text] [Related]
3. Glycoprotein Nonmetastatic Melanoma B (Gpnmb)-Positive Macrophages Contribute to the Balance between Fibrosis and Fibrolysis during the Repair of Acute Liver Injury in Mice. Kumagai K; Tabu K; Sasaki F; Takami Y; Morinaga Y; Mawatari S; Hashimoto S; Tanoue S; Kanmura S; Tamai T; Moriuchi A; Uto H; Tsubouchi H; Ido A PLoS One; 2015; 10(11):e0143413. PubMed ID: 26599547 [TBL] [Abstract][Full Text] [Related]
4. Gpnmb secreted from liver promotes lipogenesis in white adipose tissue and aggravates obesity and insulin resistance. Gong XM; Li YF; Luo J; Wang JQ; Wei J; Wang JQ; Xiao T; Xie C; Hong J; Ning G; Shi XJ; Li BL; Qi W; Song BL Nat Metab; 2019 May; 1(5):570-583. PubMed ID: 32694855 [TBL] [Abstract][Full Text] [Related]
5. Prevention and reversal of lipotoxicity-induced hepatic insulin resistance and steatohepatitis in mice by an antioxidant carotenoid, β-cryptoxanthin. Ni Y; Nagashimada M; Zhan L; Nagata N; Kobori M; Sugiura M; Ogawa K; Kaneko S; Ota T Endocrinology; 2015 Mar; 156(3):987-99. PubMed ID: 25562616 [TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory role of Gpnmb in adipose tissue of mice. Nickl B; Qadri F; Bader M Sci Rep; 2021 Oct; 11(1):19614. PubMed ID: 34608215 [TBL] [Abstract][Full Text] [Related]
7. Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue. Kudo H; Yata Y; Takahara T; Kawai K; Nakayama Y; Kanayama M; Oya T; Morita S; Sasahara M; Mann DA; Sugiyama T Liver Int; 2009 Aug; 29(7):988-96. PubMed ID: 19386026 [TBL] [Abstract][Full Text] [Related]
8. Free fatty acids and IL-6 induce adipocyte galectin-3 which is increased in white and brown adipose tissues of obese mice. Krautbauer S; Eisinger K; Hader Y; Buechler C Cytokine; 2014 Oct; 69(2):263-71. PubMed ID: 25043674 [TBL] [Abstract][Full Text] [Related]
9. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis. Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126 [TBL] [Abstract][Full Text] [Related]
10. Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis. Uno M; Kurita S; Misu H; Ando H; Ota T; Matsuzawa-Nagata N; Kita Y; Nabemoto S; Akahori H; Zen Y; Nakanuma Y; Kaneko S; Takamura T Hepatology; 2008 Jul; 48(1):109-18. PubMed ID: 18571789 [TBL] [Abstract][Full Text] [Related]
11. IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet. Luo XY; Takahara T; Kawai K; Fujino M; Sugiyama T; Tsuneyama K; Tsukada K; Nakae S; Zhong L; Li XK Am J Physiol Gastrointest Liver Physiol; 2013 Dec; 305(12):G891-9. PubMed ID: 24136786 [TBL] [Abstract][Full Text] [Related]
12. Adverse left ventricular remodeling by glycoprotein nonmetastatic melanoma protein B in myocardial infarction. Järve A; Mühlstedt S; Qadri F; Nickl B; Schulz H; Hübner N; Özcelik C; Bader M FASEB J; 2017 Feb; 31(2):556-568. PubMed ID: 28148779 [TBL] [Abstract][Full Text] [Related]